RESEARCH TRIANGLE PARK, NC, October 6, 2003 - Webfargo Data Security, Inc., a premier provider of managed security services and information protection solutions, announced today that it has been selected to provide IT security management for Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH).
The project includes deployment, network reconfiguration, and ongoing management of security devices. Webfargo will monitor and respond to security issues and provide an ongoing support structure as Inspire Pharmaceuticals continues to grow.
"Approximately 60% of our clients rely on Webfargo for day-to-day management of firewalls, Intrusion Detection Systems, or both," said Tyler Salisbury, President and Managing Partner of Webfargo, "These services offer a great way for organizations to receive expert management of their security devices, while they concentrate on their core business."
In addition to other services, Inspire Pharmaceuticals is using Webfargo's Managed Firewall Service, which includes monitoring and reporting, rulebase changes, backups, log review, maintenance, and troubleshooting.
Inspire Pharmaceuticals has plans for rapid corporate growth, and will rely heavily on Information Technology for communication. "Inspire needs their network available and secure 24/7," said Salisbury, "Webfargo will provide proactive administration to insure that this is the case."
"It was an easy decision for us," said Chris Brown, Manager, IT Systems at Inspire Pharmaceuticals, "We get a level of support comparable to a full time security professional, at a much lower cost. Knowing that Webfargo is handling our security allows me to focus on keeping our infrastructure running efficiently. They are a valued partner."
About Webfargo Data Security
Webfargo was founded in 2001 by veterans of the Research Triangle technology industry to provide tactical security services and information protection solutions that empower companies to develop and enforce security policies, set and attain security objectives, monitor and respond to network events, and protect intellectual property and critical data in the enterprise and e-business.
For more information visit www.webfargo.com, or call us at (919) 281-0175.
About Inspire Pharmaceuticals
Inspire Pharmaceuticals, Inc. discovers and develops new drugs to treat diseases characterized by deficiencies in the body's innate defense mechanisms of mucosal hydration and mucociliary clearance, as well as other non-mucosal disorders. Mucosal defense mechanisms are the natural way that the body defends its mucosal surfaces against dust, pollutants, bacteria and viruses. Inspire's lead product candidates target ophthalmic and respiratory diseases with inadequate current treatments and which represent large therapeutic market opportunities. Inspire has development and commercialization alliances with Allergan, Inc., Santen Pharmaceutical Co., Ltd. and Kirin Brewery Co., Ltd., and has a collaboration with Cystic Fibrosis Foundation Therapeutics. Inspire's products are based on proprietary technology relating to P2Y2 receptors and to non-P2Y2 receptors that show therapeutic promise, including P2Y12.